Diabetes may increase risk of developing dementia, study finds
NEW YORK — A study published in the Sept. 20 issue of Neurology, the medical journal of the American Academy of Neurology, found a link between diabetes and the development of dementia.
Japanese researchers analyzed data of 1,017 study participants, ages 60 years and older, who were given a glucose tolerance test after an overnight fast to determine if they had diabetes. After being monitored over a 15-year period, researchers discovered that 41-out-of-150 diabetic participants developed dementia (27%), compared with 115-out-of-559 people without diabetes who developed dementia (21%).
The results remained the same after the researchers accounted for such factors as high blood pressure, high cholesterol and smoking. The risk of dementia also was higher in people who did not have diabetes, but had impaired glucose tolerance, a condition known as prediabetes.
"Our findings emphasize the need to consider diabetes as a potential risk factor for dementia," said study author Yutaka Kiyohara, of Kyushu University in Fukuoka, Japan. "Diabetes is a common disorder, and the number of people with it has been growing in recent years all over the world. Controlling diabetes is now more important than ever."
In the meantime the use of pharmaceutical medications have at least helped Alzheimer's patients to have some success. http://bit.ly/n8m4Yp
Walgreens taps SoCore Energy to roll out solar installations in Ohio market
CHICAGO — Walgreens is looking to roll out solar installations at its Ohio-area stores, thanks to a new partnership with a Chicago-based solar developer.
The retailer said that it selected SoCore Energy to provide 90 solar installations for the Ohio-based stores. The partnership began earlier this month with the construction of 20 solar installations at Walgreens stores in Cincinnati. Walgreens and SoCore Energy said that the first 53 solar installations are slated to be completed by Nov. 11.
SoCore said it expects to use Power-One as its exclusive provider of inverters for the projects, while U.S. solar manufacturer SolarWorld will supply high-performance solar panels for the effort.
Walgreens also is marking its 100th solar installation in Mason, Ohio, on Sept. 23, which will include solar demonstrations and feature such guest speakers as White House Council on Environmental Quality chair Nancy Sutley, Walgreens president of community management and store operations Mark Wagner and SoCore Energy president Pete Kadens.
“Walgreens’ impressive sustainability efforts include this substantial commitment to solar power and on-site renewable energy,” Kadens said. “These projects are certainly indicative of Walgreens intent to be one of the most environmentally considerate retailers in the world.”
Walgreens will lease the arrays from SoCore for 10 years.
No comments found
Mylan, Roche reach deal over cancer drug
PITTSBURGH — Generic drug maker Mylan has entered an agreement with Hoffmann La Roche concerning its version of an oral chemotherapy drug.
Mylan announced Wednesday that it had entered a settlement and license agreement with Hoffmann La Roche resolving a patent infringement lawsuit over Xeloda (capecitabine) tablets, a drug used to treat breast and colorectal cancers that have spread to other parts of the body.
The litigation was dismissed Tuesday, though additional details of the deal were not disclosed, and it is still subject to review by the Department of Justice and the Federal Trade Commission.
Xeloda had sales of $570 million during the 12-month period ended in June, according to IMS Health.
No comments found